Tarsons Products Board Approves FY26 Audited Results; Reappoints Grant Thornton Bharat LLP
Tarsons Products Limited's Board approved audited standalone and consolidated financial results for FY26, ending March 31, 2026. The company reported Q4 FY26 revenue of ₹120.03 crore and full-year revenue of ₹422.51 crore. Net profit for Q4 FY26 was ₹5.04 crore, and for FY26 was ₹29.77 crore. M/s. Grant Thornton Bharat LLP was reappointed as Internal Auditors for FY27.
The approval of audited financial results is a routine corporate action. The reappointment of internal auditors is also standard procedure. The impact is considered medium as it confirms financial performance and operational continuity but does not introduce significant new strategic elements.
The announcement reports the approval of audited financial results and the reappointment of internal auditors. While the results are routine, there are no particularly positive or negative indicators highlighted.
Tarsons Products Limited announced the outcome of its Board meeting held on May 22, 2026. The Board has approved the audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026. The statutory auditors, M/s. Price Waterhouse Chartered Accountants LLP, have issued an unmodified opinion on these results.
Furthermore, upon the recommendation of the Audit Committee, the Board of Directors has approved the re-appointment of M/s. Grant Thornton Bharat LLP as the Internal Auditors of the Company for the Financial Year 2026-27. The company has also confirmed that the financial results will be hosted on its website.
The detailed financial results include revenue from operations for the quarter ended March 31, 2026, amounting to ₹120.03 crore and for the full financial year ₹422.51 crore. The net profit for the quarter was ₹5.04 crore, and for the full year, it was ₹29.77 crore. The company's consolidated assets stood at ₹1,185.82 crore as of March 31, 2026, with total liabilities at ₹551.13 crore.
What to do with a filing like this
Tarsons Products Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Tarsons Products Limited. Read the original for the full detail.